Guardian Pharmacy Services (GRDN) Earnings Date, Estimates & Call Transcripts $21.46 -0.34 (-1.56%) As of 03:59 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Guardian Pharmacy Services Earnings Summary Guardian Pharmacy Services issued Q1 2025 earnings on May 12, 2025, reporting an EPS of $0.21, which missed the consensus estimate of $0.22 by $0.01. Quarterly revenue was reported to be $329.31 million, above the consensus estimate of $321.21 million. With a trailing EPS of $0.00, Guardian Pharmacy Services' earnings are expected to decrease -3.45% next year, from $0.87 to $0.84 per share. Upcoming Q2 Earnings DateAug. 11After Market ClosesEstimatedConsensus EPS (May. 12) $0.22 Actual EPS (May. 12) $0.21 Missed By -$0.01 Actual Revenue (May. 12) $329.31MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)GRDN Upcoming EarningsGuardian Pharmacy Services' next earnings date is estimated for Monday, August 11, 2025, based on past reporting schedules. Powered by Get Guardian Pharmacy Services Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Guardian Pharmacy Services and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGRDN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GRDN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Guardian Pharmacy Services Analyst EPS EstimatesCurrent Year EPS Consensus Estimate $0.87 EPSNext Year EPS Consensus Estimate $0.84 EPS Guardian Pharmacy Services Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/11/2025(Estimated)--------5/12/2025Q1 2025$0.22$0.21 -$0.01$0.15$321.21M$329.31M11/12/2024Q3 2024$0.19-$2.00 -$2.19-$2.00$303.21M$314.39M Guardian Pharmacy Services Earnings - Frequently Asked Questions When is Guardian Pharmacy Services's earnings date? Guardian Pharmacy Services has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 11th, 2025 based off last year's report dates. Learn more on GRDN's earnings history. What guidance has Guardian Pharmacy Services issued on next quarter's earnings? Guardian Pharmacy Services updated its FY 2025 earnings guidance on Tuesday, April, 22nd. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Did Guardian Pharmacy Services beat their earnings estimates last quarter? In the previous quarter, Guardian Pharmacy Services (NYSE:GRDN) missed the analysts' consensus estimate of $0.22 by $0.01 with a reported earnings per share (EPS) of $0.21. Learn more on analysts' earnings estimate vs. GRDN's actual earnings. How can I listen to Guardian Pharmacy Services's earnings conference call? The conference call for Guardian Pharmacy Services's latest earnings report can be listened to online. Listen to Conference Call How can I read Guardian Pharmacy Services's conference call transcript? The conference call transcript for Guardian Pharmacy Services's latest earnings report can be read online. Read Transcript How much revenue does Guardian Pharmacy Services generate each year? Guardian Pharmacy Services (NYSE:GRDN) has a recorded annual revenue of $1.28 billion. What is Guardian Pharmacy Services's EPS forecast for next year? Guardian Pharmacy Services's earnings are expected to decrease from $0.87 per share to $0.84 per share in the next year, which is a -3.45% change. More Earnings Resources from MarketBeat Related Companies BOOT Earnings Results W Earnings Results RUSHB Earnings Results TBBB Earnings Results ASO Earnings Results CSAN Earnings Results VSCO Earnings Results CWH Earnings Results SVV Earnings Results RVLV Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Ollie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode DealCrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns? This page (NYSE:GRDN) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersFPV Drone Innovator Secures Major Defense ContractIn May, Ukraine launched Operation Spider Web - a 117-drone FPV swarm that devastated Russian fuel depots and ...The Tomorrow Investor | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredJune 23 Could Trigger $40 Trillion ShiftJune 23 Could Trigger Huge Breakthrough In Under-the-Radar Tech On June 23, scientists will quietly gather ...Stansberry Research | SponsoredElon's silence is deafeningElon Musk tweets constantly—about DOGE, Tesla controversies, and more... But he's oddly quiet about this. ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GRDN Stock Free GRDN Stock Alerts